Recordati Overview
Share Price
$45.38
(As of Wednesday Closing)
Recordati General Information
Description
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth strategy. The vast majority of the company's revenue is generated in Italy, followed by France and Germany. Recordati reports two operating segments: specialty and primary care and rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.
Want to dig into this profile?
We’ll help you find what you need
Learn more
Recordati Stock Performance
(As of Tuesday closing)
| Stock Price |
Previous Close |
52 wk Range |
Market Cap |
Shares |
Average Volume |
EPS |
| $45.38 |
$46.49 |
$31.82 - $49.11 |
$9.3B |
206M |
594K |
$2.10 |
Recordati Financials Summary
In Thousands,
USD
|
TTM
31-Mar-2020
|
FY 2019
31-Dec-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
| EV |
9,771,251 |
9,142,629 |
7,751,754 |
9,457,841 |
| Revenue |
1,698,202 |
1,658,847 |
1,595,727 |
1,452,699 |
| EBITDA |
628,056 |
607,603 |
586,904 |
508,647 |
| Net Income |
431,090 |
412,879 |
368,624 |
325,656 |
| Total Assets |
3,113,246 |
3,146,485 |
2,472,278 |
2,467,077 |
| Total Debt |
1,204,502 |
1,232,809 |
901,550 |
816,696 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Recordati Valuation & Funding
| Deal Type |
Date |
Amount |
Valuation/
EBITDA |
Post-Val |
Status |
Debt |
This information is available in the PitchBook Platform. To explore Recordati‘s full profile, request access.
Request a free trial
Recordati Competitors (32)
| Company Name |
Financing Status |
Location |
Employees |
Total Raised |
Last Financing Date/Type |
Last Financing
Amount |
| Abbott India |
Corporation |
Mumbai, India |
0000 |
|
|
|
| 00000000 000000000 |
Corporation |
Gaithersburg, MD |
0000 |
000.00 |
000000000 |
000.00 |
| 000000 00000000000 |
Corporation |
Montreal, Canada |
000 |
|
000000000 |
|
| 00000000000 |
Formerly PE-Backed |
Cambridge, United Kingdom |
00000 |
000 |
00000000 |
000 |
| 000 |
Corporation |
Parkville, Australia |
0000 |
|
0000 |
|
Recordati Executive Team (9)
| Name |
Title |
Board Seat |
Contact Info |
| Luigi La Corte |
Chief Financial Officer |
|
|
| Sorin Chiutu |
General Manager |
|
|
| Andrea Recordati |
Vice President, Managing Director, Vice Chairman and Chief Executive Officer |
|
|
| Walter Bevilacqua |
Vice President and Director of Corporate Development |
|
|
| Marianne Tatschke |
Director, Investor Relations & Corporate Communications |
|
|
2 Former Executives
Recordati Investors
| Investor Name |
Investor Type |
Holding |
Investor Since |
Participating Rounds |
Contact Info |
This information is available in the PitchBook Platform. To explore Recordati‘s full profile, request access.
Request a free trial
Recordati
Investments
&
Acquisitions (20)
To view Recordati‘s complete investment and acquisition history, request access >>
| Company Name |
Deal Date |
Deal Type |
Deal Size |
Industry |
Lead Partner |
| 00000000 (00000000 |
23-Oct-2019 |
000000000 00000 00 |
00000 |
Buildings and Property |
0000000 000000000 00.0 |
| 000000000 |
31-Dec-2018 |
000000000000000000 |
000.00 |
Medical Supplies |
000000 000000000 |
| 0000000 00000 |
11-Jun-2018 |
000000000000000000 |
00000 |
Food Products |
0000000 000000000 00.0 |
| 00000 00000 000000 |
18-Dec-2017 |
000000000 00000 00 |
|
Buildings and Property |
000000 000000000 |
| AstraZeneca (Seloken/Seloken ZOK/Logimax) |
25-May-2017 |
Corporate Asset Purchase |
00000 |
Other Pharmaceuticals and Biotechnology |
000000 000000000 |
Recordati Subsidiaries (7)
| Company Name |
Industry |
Location |
Founded |
| Pro Farma |
Distributors/Wholesale (B2C) |
Baar, Switzerland |
1995 |
| 0000000 00000 |
Food Products |
Milan, Italy |
0000 |
| 000000000 |
Medical Supplies |
Boulogne, France |
0000 |
| 000000 000000 |
Pharmaceuticals |
Puteaux, France |
0000 |
| 000000 000000 |
Pharmaceuticals |
Ariana, Tunisia |
0000 |
Recordati Exits (1)
| Company Name |
Exit Date |
Exit Type |
Exit Size |
Status |
Buyers |
| 00000000000000 |
01-Jan-1986 |
000000000000000000 |
|
Completed |
|